Regencell Bioscience (RGC) has had the highest return since March 20, 2024 by a mid-cap US stock, returning 16,419.7%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 16,419.74% |
United States Antimony (UAMY) | 5,889.25% |
Power Solutions International, Inc Common Stock (PSIX) | 4,296.3% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Quantum Computing (QUBT) | 1,734.19% |
Eos Energy Enterprises (EOSE) | 1,605% |
GeneDx (WGS) | 1,345.81% |
Innodata (INOD) | 1,194.45% |
Uniqure (QURE) | 1,106.61% |
CommScope (COMM) | 1,025.93% |
Ondas (ONDS) | 1,003.06% |
Centrus Energy (LEU) | 908.4% |
Terawulf (WULF) | 718.71% |
Cidara Therapeutics (CDTX) | 709.97% |
Mesoblast (MESO) | 699.12% |
Applied Digital (APLD) | 696.28% |
Sezzle (SEZL) | 650.7% |
Verona Pharma PLC ADR (VRNA) | 598.76% |
Nuscale Power (SMR) | 593.68% |
Perpetua Resources (PPTA) | 593.42% |
Abivax SA American Depositary Shares (ABVX) | 555.9% |
Planet Labs PBC (PL) | 551.71% |
TMC the metals (TMC) | 528.82% |
Solaris Energy Infrastructure (SEI) | 519.71% |
Dave (DAVE) | 512.31% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
